Find Federal Grants
Substance Abuse and Mental Health Services Adminis · SM-20-009
Maintaining and Strengthening Institutional Capacity of Maputo City Province Health Directorate in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH20-2055
Enhancing Strategic Information Capacity for HIV/AIDS Programs towards Sustaining Epidemic Control in Kenya through Monitoring and Evaluation and Data Science under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH20-2043
Scaling Up High-Impact HIV Prevention, Testing and Treatment Models in Central America under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH20-2013
Technical Assistance to the Provincial Health Offices in Zambia to Support Optimized HIV Case Finding, Treatment, Viral Suppression, Retention and HIV Epidemic Control under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH20-2075
Achieving Voluntary Medical Male Circumcision (VMMC) Saturation in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH20-2051
Malaria Operations Research to Improve Malaria Control and Reduce Morbidity and Mortality in Western Kenya
Centers for Disease Control and Prevention - ERA · RFA-GH-20-002
Develop, Implement, and Evaluate Evidence-based, Innovative Approaches to Prevent, Find, and Cure Tuberculosis in High-Burden Settings
Centers for Disease Control and Prevention - ERA · RFA-GH-20-001
Methods and Measurement in Research with Sexual and Gender Minority (SGM) Populations (R21- Clinical Trials Not Allowed)
National Institutes of Health · RFA-MD-20-005
Health Promotion and Disease Prevention Research Centers: 2020 Special Interest Project Competitive Supplements (SIPS)
Centers for Disease Control and Prevention - ERA · RFA-DP-20-003
Maintaining and Strengthening Institutional Capacity of Maputo Province Health Directorate in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH20-2056
Support HIV/AIDS Prevention, Care, and Treatment Activities for Mothers, Children, and Families under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH20-2034
Strengthening the Zambia Ministry of Health's Capacity to Provide Leadership to the National HIV/AIDS Response through Coordination, Policy Development, Mentorship and Training under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH20-2072
Comprehensive Approaches to Sustaining the Health System and HIV Response in the Republic of Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGH · CDC-RFA-GH20-2058
HQ Supported Development, Implementation, Use and Evaluation of Interoperable Health Information Systems to Achieve HIV/AIDS and TB Epidemic Control through Improved Health Informatics Policy, Governance, Workforce Capacity, and Systems under PEPFAR
Centers for Disease Control - CGH · CDC-RFA-GH20-2036
Support and Capacity Building for Polio Eradication, Control of Other Vaccine Preventable Diseases, and Immunization Systems Strengthening in Africa.
Centers for Disease Control - CGH · CDC-RFA-GH20-2001
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)
National Institutes of Health · RFA-CA-20-023
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)
National Institutes of Health · RFA-CA-20-024
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
National Institutes of Health · RFA-CA-20-022
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
National Institutes of Health · RFA-CA-20-026